| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cd19/cd22 car t-cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Leukemia Prolymphocytic B-Cell[MeSHID:D054403] T-Lymphocyte[MeSHID:D013601] leukemia[MeSHID:D007938] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] B-Cell Lymphomas[MeSHID:D016393] |
NA | phase 1 | unknown |
| cd19/cd22 car t-cells | b-cell receptor cd22 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Leukemia Prolymphocytic B-Cell[MeSHID:D054403] T-Lymphocyte[MeSHID:D013601] leukemia[MeSHID:D007938] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] B-Cell Lymphomas[MeSHID:D016393] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||